Results
1 -
3 of
3
(Click
here to explore results)
- Synthesis and evaluation of [11C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer's disease prior to amyloid β aggregation. Allen F. Brooks, Isaac M. Jackson, Xia Shao, George W. Kropog, Phillip Sherman, Carole A. Quesada, Peter J. H. Scott
, Med. Chem. Commun.
, 2015
, 6
, 1065
- Pharmacophore-driven identification of human glutaminyl cyclase inhibitors from foods, plants and herbs unveils the bioactive property and potential of Azaleatin in the treatment of Alzheimer's disease. Keng-Chang Tsai, Yi-Xuan Zhang, Hsiang-Yun Kao, Kit-Man Fung, Tien-Sheng Tseng
, Food Funct.
, 2022
, 13
, 12632
- In vitro and in silico determination of glutaminyl cyclase inhibitors. Phuong-Thao Tran, Van-Hai Hoang, Jeewoo Lee, Tran Thi Thu Hien, Nguyen Thanh Tung, Son Tung Ngo
, RSC Adv.
, 2019
, 9
, 29619